{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:46:27Z","timestamp":1762145187438},"reference-count":16,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.bulcan.2016.05.006","type":"journal-article","created":{"date-parts":[[2016,6,23]],"date-time":"2016-06-23T22:59:54Z","timestamp":1466722794000},"page":"730-734","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Association of serum prostate-specific antigen levels with the results of the prostate needle biopsy"],"prefix":"10.1016","volume":"103","author":[{"given":"Hamid","family":"Janbaziroudsari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arezoo","family":"Mirzaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nasrollah","family":"Maleki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.bulcan.2016.05.006_bib0085","first-page":"805","article-title":"Epidemiology of prostate cancer: current status","volume":"19","author":"Tao","year":"2015","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.bulcan.2016.05.006_bib0090","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3322\/caac.21166","article-title":"Cancer statistics, 2013","volume":"63","author":"Siegel","year":"2013","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.bulcan.2016.05.006_bib0095","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/jnci\/djr500","article-title":"Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13years of follow-up","volume":"104","author":"Andriole","year":"2012","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"10.1016\/j.bulcan.2016.05.006_bib0100","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1177\/1403494815597871","article-title":"Screening for cancer of the prostate: do we have a state of the art?","volume":"43","author":"Lieberman","year":"2015","journal-title":"Scand J Public Health"},{"key":"10.1016\/j.bulcan.2016.05.006_bib0105","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/S0140-6736(03)12890-5","article-title":"Screening for prostate cancer","volume":"361","author":"Frankel","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.bulcan.2016.05.006_bib0110","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0140-6736(94)91109-6","article-title":"Changes in prostate cancer incidence and treatment in USA","volume":"343","author":"Lu-Yao","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.bulcan.2016.05.006_bib0115","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1016\/S0022-5347(01)64722-0","article-title":"Use of radical prostatectomy among Medicare beneficiaries before and after the introduction of prostate specific antigen testing","volume":"157","author":"Lu-Yao","year":"1997","journal-title":"J Urol"},{"key":"10.1016\/j.bulcan.2016.05.006_bib0120","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1001\/jama.1995.03520310046028","article-title":"The role of increasing detection in the rising incidence of prostate cancer","volume":"273","author":"Potosky","year":"1995","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.bulcan.2016.05.006_bib0125","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3322\/canjclin.52.1.8","article-title":"American Cancer Society guidelines for the early detection of cancer","volume":"52","author":"Smith","year":"2002","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.bulcan.2016.05.006_bib0130","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1056\/NEJM198710083171501","article-title":"Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate","volume":"317","author":"Stamey","year":"1987","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.bulcan.2016.05.006_bib0135","doi-asserted-by":"crossref","first-page":"209","DOI":"10.6004\/jnccn.2004.0019","article-title":"Role of complexed PSA in the early detection of prostate cancer","volume":"2","author":"Naya","year":"2004","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.bulcan.2016.05.006_bib0140","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1056\/NEJMp1112191","article-title":"Prostate-cancer screening\u2013what the U.S. Preventive Services Task Force left out","volume":"365","author":"Brett","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bulcan.2016.05.006_bib0145","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1056\/NEJMoa0810084","article-title":"Screening and prostate-cancer mortality in a randomized European study","volume":"360","author":"Schr\u00f6der","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bulcan.2016.05.006_bib0150","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1056\/NEJMoa0810696","article-title":"Mortality results from a randomized prostate-cancer screening trial","volume":"360","author":"Andriole","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bulcan.2016.05.006_bib0155","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1056\/NEJM199104253241702","article-title":"Measurement of prostate-specific antigen in serum as a screening test for prostate cancer","volume":"324","author":"Catalona","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bulcan.2016.05.006_bib0160","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.eururo.2012.02.054","article-title":"International variation in prostate cancer incidence and mortality rates","volume":"61","author":"Center","year":"2012","journal-title":"Eur Urol"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000745511630087X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000745511630087X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T02:21:19Z","timestamp":1536632479000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000745511630087X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":16,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S000745511630087X"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2016.05.006","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of serum prostate-specific antigen levels with the results of the prostate needle biopsy","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2016.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}